Investopedia: A Look Back At The Year In Biotech

Despite 2012 being a year where investors were increasingly skittish as the year wore on, the exceptionally risky biotechnology industry enjoyed an exceptionally good year. While the group has come off a bit from its peak in the early fall, the group is up more than 30% year to date - making it not only a strong outperformer relative to the S&P 500 (which is up about 12%), but one of the best-performing groups of the year.

Continue reading here:
http://www.investopedia.com/stock-analysis/2012/A-Look-Back-At-The-Year-In-Biotech-MDVN-ONXX-ARNA-SRPT1228.aspx